Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on January 13. Analyst Mike Kratky from ...

DXCM's top line reflects strong demand for its CGM sensors. International expansion is also driving sales higher. Gross ...

Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024 ...

Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report). The associated price target remains ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

DexCom (DXCM) shares rise 6% premarket after setting financial forecast for 2025, projecting 14% revenue growth over 2024 on ...

After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...

Today, Benzinga 's options scanner spotted 11 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $77.76 which represents a decrease of $-2.33 or -2.91% from the prior close of $80.09. The stock opened at $79.5 and touched a low ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Baird has recently reduced DexCom Inc (DXCM) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 26, 2024, JP Morgan had reduced the stock from a Overweight ...